Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 37,201 $ 165,586
Restricted cash 2,835 2,518
Short-term investments 50,699 0
Accounts receivable, net of allowance of $0 and $39, respectively 5,101 2,629
Prepaid expenses and other current assets 5,487 6,264
Contract assets 5,915 1,678
Total current assets 107,238 178,675
Property and equipment - net 78,157 70,551
Goodwill 9,393 9,393
Investment in equity method investees 4,150 4,002
Intangible assets - net 2,058 2,480
Satellite procurement work in process 41,664 40,102
Other assets 1,675 560
Total assets 244,335 305,763
Current liabilities:    
Accounts payable and accrued liabilities 14,579 10,837
Amounts payable to equity method investees 1,667 5,613
Contract liabilities - current 9,018 11,266
Other current liabilities 1,531 2,819
Total current liabilities 26,795 30,535
Liability for estimated contract losses 1,966 6,054
Long-term contract liabilities 42 568
Derivative liabilities 6,296 16,925
Long-term debt - net of current portion 72,956 71,408
Other liabilities 2,867 653
Total liabilities 110,922 126,143
Commitments and contingencies (Note 17)
Stockholders’ equity:    
Class A common stock, $0.0001 par value-authorized, 300,000 shares; issued, 121,357 and 117,160 shares; outstanding, 118,906 shares and 114,452 shares as of September 30, 2022 and December 31, 2021, respectively. 12 11
Additional paid-in capital 663,654 650,518
Accumulated deficit (530,253) (470,909)
Total stockholders’ equity 133,413 179,620
Total liabilities and stockholders’ equity $ 244,335 $ 305,763